# FDA 483 - Michelle Sato, M.D. - August 13, 2021

Source: https://www.globalkeysolutions.net/records/483/michelle-sato-md/7467947e-d386-4c26-bc5d-ad5b47a5eb9b

> FDA 483 for Michelle Sato, M.D. on August 13, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Michelle Sato, M.D.
- Inspection Date: 2021-08-13
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV

## Related Documents

- [483 - 2021-08-13](https://www.globalkeysolutions.net/records/483/michelle-sato-md/5e2c9999-8593-4923-817b-24460c835ee7)
- [483 - 2021-08-13](https://www.globalkeysolutions.net/records/483/michelle-sato-md/bb31c8d8-d552-4637-a4e5-1369e5eb0991)

## Related Officers

- [issuing_officer](https://www.globalkeysolutions.net/people/courtney-r-bratina/3ad4bfd5-d0da-4801-8e90-a5a3ba9291c3)

Company: https://www.globalkeysolutions.net/companies/michelle-sato-md/6b439c3c-fcb2-4d11-aa37-6c54e8100ae2

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6